BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35146926)

  • 1. Vision-related quality of life and visual ability in patients with autosomal dominant optic atrophy.
    Eckmann-Hansen C; Bek T; Sander B; Larsen M
    Acta Ophthalmol; 2022 Nov; 100(7):797-804. PubMed ID: 35146926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal vessel diameters decrease with macular ganglion cell layer thickness in autosomal dominant optic atrophy and in healthy subjects.
    Rönnbäck C; Grønskov K; Larsen M
    Acta Ophthalmol; 2014 Nov; 92(7):670-4. PubMed ID: 24612963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular sensitivity and fixation patterns in patients with autosomal dominant optic atrophy.
    Rönnbäck C; Larsen M
    Dan Med J; 2014 Sep; 61(9):A4888. PubMed ID: 25186535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of the macula indicates early completion of structural deficit in autosomal-dominant optic atrophy.
    Rönnbäck C; Milea D; Larsen M
    Ophthalmology; 2013 Dec; 120(12):2672-2677. PubMed ID: 24120325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
    Ham M; Han J; Osann K; Smith M; Kimonis V
    Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of OPA1-related autosomal dominant optic atrophy.
    Cohn AC; Toomes C; Hewitt AW; Kearns LS; Inglehearn CF; Craig JE; Mackey DA
    Br J Ophthalmol; 2008 Oct; 92(10):1333-6. PubMed ID: 18653586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy.
    Rönnbäck C; Nissen C; Almind GJ; Grønskov K; Milea D; Larsen M
    Acta Ophthalmol; 2015 Dec; 93(8):762-6. PubMed ID: 26385429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.
    Votruba M; Thiselton D; Bhattacharya SS
    Br J Ophthalmol; 2003 Jan; 87(1):48-53. PubMed ID: 12488262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Function and Inner Retinal Structure in Relation to Birth Factors in Autosomal Dominant Optic Atrophy.
    Eckmann-Hansen C; Bek T; Sander B; Larsen M
    Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):32. PubMed ID: 37498569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation.
    Russo A; Delcassi L; Marchina E; Semeraro F
    Ophthalmic Genet; 2013; 34(1-2):69-74. PubMed ID: 22779427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiethnic involvement in autosomal-dominant optic atrophy in Singapore.
    Loo JL; Singhal S; Rukmini AV; Tow S; Amati-Bonneau P; Procaccio V; Bonneau D; Gooley JJ; Reynier P; Ferré M; Milea D
    Eye (Lond); 2017 Mar; 31(3):475-480. PubMed ID: 27858935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.
    Fuhrmann N; Alavi MV; Bitoun P; Woernle S; Auburger G; Leo-Kottler B; Yu-Wai-Man P; Chinnery P; Wissinger B
    J Med Genet; 2009 Feb; 46(2):136-44. PubMed ID: 19181907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy.
    Van Bergen NJ; Crowston JG; Kearns LS; Staffieri SE; Hewitt AW; Cohn AC; Mackey DA; Trounce IA
    PLoS One; 2011; 6(6):e21347. PubMed ID: 21731710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy.
    Nakamura M; Lin J; Ueno S; Asaoka R; Hirai T; Hotta Y; Miyake Y; Terasaki H
    Ophthalmology; 2006 Mar; 113(3):483-488.e1. PubMed ID: 16513463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.
    Corajevic N; Larsen M; Rönnbäck C
    Acta Ophthalmol; 2018 May; 96(3):251-256. PubMed ID: 29091347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+.
    Skidd PM; Lessell S; Cestari DM
    Semin Ophthalmol; 2013; 28(5-6):422-6. PubMed ID: 24138050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
    Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
    Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation.
    Kamakari S; Koutsodontis G; Tsilimbaris M; Fitsios A; Chrousos G
    Mol Vis; 2014; 20():691-703. PubMed ID: 24883014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.